Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.

MLA

Fukada, Ippei, et al. “Predictive Factors and Value of YpN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.” PloS One, vol. 11, no. 9, Sept. 2016, p. e0162616. EBSCOhost, https://doi.org/10.1371/journal.pone.0162616.

APA

Fukada, I., Araki, K., Kobayashi, K., Shibayama, T., Takahashi, S., Horii, R., Akiyama, F., Iwase, T., Ohno, S., Hatake, K., Hozumi, Y., Sata, N., & Ito, Y. (2016). Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer. PloS One, 11(9), e0162616. https://doi.org/10.1371/journal.pone.0162616

Chicago

Fukada, Ippei, Kazuhiro Araki, Kokoro Kobayashi, Tomoko Shibayama, Shunji Takahashi, Rie Horii, Futoshi Akiyama, et al. 2016. “Predictive Factors and Value of YpN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.” PloS One 11 (9): e0162616. doi:10.1371/journal.pone.0162616.